Sarepta Therapeutics and 4 Stocks Heading in Different Directions After Earnings

Sarepta Therapeutics (NASDAQ:SRPT) had a loss and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.46 in the quarter versus EPS of $0.35 in the year-earlier quarter. Revenue Decreased 73.24% to $3 million from the year-earlier quarter.

Sarepta Therapeutics reported adjusted EPS loss of $0.46 per share. By that measure, the company beat the mean analyst estimate of $-0.67. It missed the average revenue estimate of $5.08 million.

SRPT 20130811

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.23 in the quarter versus EPS of $-0.25 in the year-earlier quarter. Revenue Decreased 80.52% to $820,000 from the year-earlier quarter.

BioCryst Pharmaceuticals, Inc. reported adjusted EPS loss of $0.23 per share. By that measure, the company missed the mean analyst estimate of $-0.14. It missed the average revenue estimate of $2.01 million.

BCRX 20130811

Novavax, Inc. (NASDAQ:NVAX) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.08 in the quarter versus EPS of $-0.05 in the year-earlier quarter. Revenue Decreased 50.7% to $3.5 million from the year-earlier quarter.

Novavax, Inc. reported adjusted EPS loss of $0.08 per share. By that measure, the company missed the mean analyst estimate of $-0.06. It missed the average revenue estimate of $4.53 million.

NVAX 20130811

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.62 in the quarter versus EPS of $-0.68 in the year-earlier quarter. Revenue Decreased 82.98% to $320,000 from the year-earlier quarter.

AVEO Pharmaceuticals, Inc. reported adjusted EPS loss of $0.62 per share. By that measure, the company missed the mean analyst estimate of $-0.56. It missed the average revenue estimate of $4.3 million.

AVEO 20130811

US Physical Therapy Inc. (NASDAQ:USPH) delivered a profit and missed Wall Street’s expectations, BUT beat the revenue expectation. Adjusted Earnings Per Share were the same at $0.41 in the quarter as EPS of $0.41 in the year-earlier quarter. Revenue Rose 5.1% to $67.22 million from the year-earlier quarter.

US Physical Therapy Inc. reported adjusted EPS income of $0.41 per share. By that measure, the company missed the mean analyst estimate of $0.42. It beat the average revenue estimate of $66.49 million.

USPH 20130811

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.